Invisible but devastating, traumatic brain injury and post-traumatic stress leave a tragic mark on our soldiers, our veterans, and members of our community.

Company Plans to Conduct Additional Analyses of These Preliminary Data

At the Annual American Psychiatric Association (APA) meeting held May 14-18, Dr. Susan McElroy, Chief Research Officer at Lindner Center of HOPE presented research evidence supporting the broadening of the concept of Bipolar Disorder.  Colleagues Dr. Mari Maj, from Italy and Dr. Stephen Strakowski, Professor and Chair at University of Cincinnati Department of Psychiatry & Behavioral Health argued that the diagnostic criteria should not be broadened.  

Adjunctive therapy being examined for those who have not responded to SSRI treatment

Adults who struggle with Obsessive Compulsive Disorder, even with treatment, can participate in a clinical trial to help doctors evaluate an investigational medication

Collaboration will bring together regional, national and international experts to improve research, clinical care and education surrounding mood disorders.

Regional and international experts in mood disorders from University of Cincinnati Academic Health Center, Lindner Center of HOPE and Cincinnati Children’s Hospital Medical Center have joined to form the Cincinnati Mood Disorders Consortium (CMDC).

Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX) today announced results from a 24-week open-label study demonstrating that treatment with Contrave(R) resulted in significant improvements in depressive symptoms that was accompanied by weight loss and improved control of eating in overweight and obese patients with major depression.

As part of a global study, the Center’s findings will contribute to data being collected around the world proving or disproving the efficacy of a medication, currently on the market for adults, in adolescents.  The medication is considered investigational and is not approved by the United States Food & Drug Administration for this indication.

Susan L. McElroy, M.D., Chief Research Officer, and Paul E. Keck, Jr., President and CEO, Lindner Center of HOPE, co-edited a book titled, Antiepileptic Drugs To Treat Psychiatric Disorders, recently published by Informa Healthcare USA, Inc. Robert M. Post, M.D., head of the Bipolar Collaborative Network, also served as editor for the publication.    
 

Susan L. McElroy, M.D., Chief Research Officer, and Paul E. Keck, Jr., President and CEO, Lindner Center of HOPE, in addition to Lindner Center of HOPE research investigators, Anna I. Guerdjikova, Ph.D., M.S.W., L.S.W. and Brian E. Martens, L.S.W., M.S., recently co-authored a review article in CNS Drugs titled Role of Antiepileptic Drugs in the Management of Eating Disorders.

 

A binge eating disorder study currently being conducted by The Research Institute at Lindner Center of HOPE was recently highlighted on Local 12's Medical Edge with Liz Bonis.